Impacto del tratamiento antitrombótico y los síndromes geriátricos en octogenarios con fibrilación auricular y cardiopatía isquémica. Fibrilación Auricular y Cardiopatía Isquémica en Longevos (FACIL)

Bonanad Lozano, Clara; Díez-Villanueva, Pablo; García Blas, Sergio; Ayesta, Ana; Ibars, Sonia; Ariza-Solé, Albert; Ferreiro, José Luis; Moreno, Raúl; Roldán, Inmaculada; Marín, Francisco; Carol Ruiz, Antoni; García Pardo, Héctor; Sanchís, Juan; Cruz-González, Ignacio; Anguita, Manuel; Cequier, Ángel; Ruiz García, Juan; Martínez-Sellés, Manuel.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 55(6): 338-342, nov.-dic. 2020. tab
Artículo en Español | IBECS (España) | ID: ibc-201036

Documentos relacionados

  1. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications.
  2. Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease.
  3. Infusion techniques for peripheral arterial thrombolysis.
  4. Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species.
  5. Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery.
  6. In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation.
  7. Improved visual outcomes of central retinal artery occlusion with local intra-arterial fibrinolysis beyond the conventional time window.
  8. Poly-<i>&#945;</i>, <i>ß</i>-<i>d</i>, <i>l</i>-Aspartyl-Arg-Gly-Asp-Ser-Based Urokinase Nanoparticles for Thrombolysis Therapy.
  9. Management of patients receiving novel antithrombotic treatment in endodontic practice: Review and clinical recommendations.
  10. Letter to the Editor.